<DOC>
	<DOCNO>NCT01884987</DOCNO>
	<brief_summary>Cerebral radiation necrosis ( CRN ) well-documented late complication radiation therapy cancer , may devastate effect patient 's quality life ( QOL ) . However , CRN regard progressive irreversible disease , standard therapy suggest CRN . In clinical practice , use monosialotetrahexosylganglioside ( GM1 ) treat CRN , find GM1 successfully reverse CRN . So carried prospective study test efficacy GM1 CRN .</brief_summary>
	<brief_title>Treatment Cerebral Radiation Necrosis With GM1 , Prospective Study</brief_title>
	<detailed_description />
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<criteria>The necrotic mass show MRI must measure two dimension . No local regional recurrence , distant metastasis . Karnofsky performance status least 70 suppose live 6 month . CRN combine local regional relapse , distant metastasis . ② CRN combine cerebrovascular disease . ③CRN combined second primary malignancy . ④ CRN without neurologic symptom sign . ⑤ CRN combine diabetes . ⑥CRN patient suppose live less 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>